Edit
Tessellate BIO
https://tessellatebio.com/Last activity: 19.05.2025
Active - Reference to 301 Moved Permanently
Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion.
Location: Netherlands, North Holland, Naarden
Employees: 11-50
Total raised: $8.46M
Investors 1
| Date | Name | Website |
| 19.05.2025 | Forbion | forbion.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.10.2023 | Seed | $8.46M | - |
Mentions in press and media 1
| Date | Title | Description |
| 17.10.2023 | Tessellate BIO Raises Initial €8M in Seed Funding | Tessellate BIO, a Nardeen, the Netherlands-based-based preclinical stage biotechnology company, has emerged from stealth with an initial €8M in Seed funding. The round was led by BioGeneration Ventures and Forbion. The company intends to us... |